Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab.
Clin Exp Dermatol
; 47(12): 2303-2305, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36006169
ABSTRACT
We report a clinical experience of treating concomitant atopic dermatitis and hidradenitis suppurativa (HS) with dupilumab. This report is particularly noticeable in terms of disease severity and treatment duration compared to previous reported cases, suggesting long-term dupilumab therapy can contribute to disease control even in patients with severe HS.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hidradenitis Supurativa
/
Dermatitis Atópica
Límite:
Humans
Idioma:
En
Revista:
Clin Exp Dermatol
Año:
2022
Tipo del documento:
Article
Pais de publicación:
ENGLAND
/
ESCOCIA
/
GB
/
GREAT BRITAIN
/
INGLATERRA
/
REINO UNIDO
/
SCOTLAND
/
UK
/
UNITED KINGDOM